If the market is always right then IMU just got crap asssets.
ALA, not even getting its IND after almost 4 years, is valued now 160m and increasing, without cash, whilst IMU is valued about 280m, without estimated $80m cash and most likely further decreasing. Won't take long and ALA is valued equally or even more based on about $5m cash and on, so far, an asset, iNKT, that wasn't considered worth to be progressed by IMU and that struggles to meet the FDA minimum ph1 criteria.
Again, is the market right and if yes, we all have invested in total crap.
GLTA
IMU Price at posting:
4.8¢ Sentiment: Buy Disclosure: Held
